Clinical Trials

The following clinical trials are currently recruiting participants. If you would like more information about the trial or how to participate, please contact the study coordinator.

Trial Name

Title

Sponsor

Condition

Status

Study Coordinator

MODIFIER
ADPKD

Identifying genetic modifiers in ADPKD

NIH

ADPKD

Recruiting

Cathy Creed

MENTOR 

Membranous nephropathy trial of Rituximab multi-center randomized controlled trial of Rituximab Vs Cycolsporine in the TX of idiopathis membranous nephropathy (IMN)

NIH

Idiopathic Membranous Nephropathy

Recruiting

Nancy Morgan

Exercise

Determine the feasibility of 12 weeks of structured aerobic exercise in patients with ESRD and generate initial estimates of its effect on cognition

Investigator initiated

(Frontiers: Heartland Institute for Clinical and Translational Research)

ESRD

Recruiting

Michelle Hansen

NIAC PKD-1

Uncontrolled, open label, pilot and feasability study of niacinamide in polycystic kidney disease

Investigator initiated

(Frontiers: Heartland Institute for Clinical and Translational Research)

ADPKD

Recruiting

Cathy Creed

PRX-102

An extension of phase 1/2, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 administered by intravenous infusion every 2 weeks for 12 weeks to adult Fabry patients

Protalix

Fabry disease

Recruiting

Cathy Creed

Kadmon

A phase 1b/2a, safety, pharmacokinetic and dose-escalation study of KD019 in subjects with ADPKD

Kadmon

ADPKD

Recruiting

Cathy Creed

Genzyme ADPKD

Assessment of intra-person variability of urinary biomarkers in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Genzyme

ADPKD

Recruiting

Judy Vun

Abbreviations: CKD, chronic kidney disease; ESRD, end-stage renal disease; ADPKD, autosomal dominant polycystic kidney disease; FSGS, focal segmental glomerulosclerosis

 

The following clinical trials are currently pending. If you would like more information about the trial or how to participate, please contact the study coordinator.

Trial Name

Title

Sponsor

Condition

Status

Study Coordinator

ICON

A phase 2 dose ranging, double-blind, placebo controlled sudy evaluating the efficacy, safety, and tolerability of GS-4997 in sbubjects with stage 3/4 diabetic kidney disease

Gilead

Stage 3/4 diabetic kidney disease

Pending

Cathy Creed

 

The following clinical trials are active and NOT currently recruiting participants. If you would like more information about the trial, please contact the study coordinator.

Trial Name

Title

Sponsor

Condition

Status

Study Coordinator

OVERTURE
291 

 A multi-center, longitudinal, observational study of subjects with ADPKD

 Otsuka

 ADPKD

Active/Not Recruiting

Cathy Creed

TEMPO 3(271)

Multi-center, open-label, extension study to evaluate the long-term efficacy and safety of oral tolvaptan tablet regimens in subjects with autosomal dominant polycystic kidney disease

Otsuka

ADPKD

Active/Not Recruiting

Debbie Griffin

CRISP 3

Consortium for radiologic imaging studies of polycystic kidney disease

NIH

ADPKD

Active/Not Recruiting

Debbie Griffin

Judy Vun

Vit D 

Impact of vitamin D therapies on monocyte function in chronic kidney disease

Internal Medicine-K12 

CKD stage 3/4

Active/Not Recruiting

Cathy Creed


Contact information

Debbie Griffin, RN - Study Coordinator     (913) 588-7691       dgriffin3@kumc.edu

Cathy Creed, RN - Study Coordinator      (913) 588-0053       ccreed@kumc.edu

Judy Vun, LPN - Study Coordinator         (913) 588-8983       jvun@kumc.edu

Michelle Hansen - Study Coordinator       (913) 588-7609      mhansen2@kumc.edu

Last modified: Jul 30, 2015
ID=x17989